Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
@article{182886,
author = {Hardik T.Deshmukh and santosh w. kulkarni},
title = {Synthesis, Characterization of Cu(II) Complex Using of (5amino-3-[(1H-benzimidazole-1-yl)methyl]-1,3,4-thiadazole-2(3H)thione) and study their antibacterial, antifungal and antiinflammatory property.},
journal = {International Journal of Innovative Research in Technology},
year = {2025},
volume = {12},
number = {2},
pages = {3616-3623},
issn = {2349-6002},
url = {https://ijirt.org/article?manuscript=182886},
abstract = {This study focuses on the synthesis, characterization, and biological evaluation of metal complexes containing the ligand 5-amino-3-[(1H-benzimidazole-1-yl)methyl]-1,3,4-thiadazole-2(3H)-thione (ABT). The ligand was synthesized by a mannich reaction , followed by complexation with Cu(II) metal ions . The resulting reagent metal complexes were characterized using a combination of spectroscopic techniques such as UV-Vis, FT-IR, NMR, Mass , which confirmed formation of ligand the coordination of the ligand to the metal centers through the sulfur and nitrogen atoms. Biological testing revealed that the synthesized metal complexes exhibited significant antibacterial and antiinflammatry antifungle activities, with the Cu(II) complexs showing the most promising results. These findings suggest that the metal complexes of ABT have potential as bioactive agents, with possible applications in drug development. Further studies are warranted to explore the mechanisms},
keywords = {},
month = {July},
}
Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.
Join NowNational Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024
Submit inquiry